Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib
Serova, Maria, Gramont, Armand, Tijeras-Raballand, Annemilaï, Santos, Célia, Riveiro, Maria Eugenia, Slimane, Khemaies, Faivre, Sandrine, Raymond, EricVolume:
71
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-013-2129-6
Date:
May, 2013
File:
PDF, 687 KB
english, 2013